Viewing Study NCT00773734


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2026-02-07 @ 5:10 AM
Study NCT ID: NCT00773734
Status: COMPLETED
Last Update Posted: 2020-05-07
First Post: 2008-10-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
None Plaque-type Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None moderate-to-severe plaque-type psoriasis View